Phosphorylation‐activated LATS1/2 induces YAP retention in the cytoplasm of RCC cells and blocks the interaction between YAP and TEAD1 to inhibit YAP mRNA expression and reduce YAP target gene expression. The gene discussed is TEAD1; the disease is renal cell carcinoma.